Clinical Trial Update: 18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients

View source ↗

Summary

A clinical trial compares 18F-PSMA PET/CT versus CT alone for assessing prostate cancer and is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-PSMA (fluorine-18 labeled PSMA radiotracer)

Snippet

Sponsor: Assiut University | Conditions: Prostate Cancer, Prostate Cancer Metastatic | Status: NOT_YET_RECRUITING